GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.7858 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.0058 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRNA3, CHRNA7, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F2, FABP3, FABP4, FLT3, GPER1, HSD17B1, HSD17B3, HTR2A, HTR2B, HTR2C, KCNH2, KDR, MCL1, MET, MTNR1B, PPARA, SRC, TRPV1, XDH |
11.585 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA1A, ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CA3, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MCL1, MMP2, MMP9, PPARA, SRC, TRPV1 |
11.3999 |
[BP] GO:0042592 |
homeostatic process
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, MCL1, MET, MTNR1B, SRC, TRPV1 |
10.1271 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADRA1A, AKR1B1, AXL, BCL2, CA3, CA9, CHRNA3, CHRNA7, CNR2, CYP1A1, CYP1B1, FABP3, HTR2A, HTR2B, HTR2C, KCNH2, KDR, SRC, TRPV1 |
9.67114 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MCL1, MET, MMP1, MMP2, MMP9, MTNR1A, PIM1, PPARA, SRC, TRPV1, XDH |
8.96098 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CA3, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MCL1, MMP2, PPARA, SRC, TRPV1 |
8.96098 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
ADRB2, AKR1B1, AR, AXL, BCL2, CA3, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GPER1, IGF1R, MMP2, MMP9, PPARA, SRC, TRPV1 |
8.96098 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, ADRA1B, ADRA1D, AKR1B1, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, FABP3, FABP4, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, MET, MTNR1B, TRPV1 |
8.77124 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MCL1, MET, MMP1, MMP2, MMP9, MTNR1A, PIM1, PPARA, SRC, TRPV1, XDH |
8.68059 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AXL, BCL2, CHRNA7, CYP1B1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MCL1, MET, SRC, XDH |
8.57991 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, AR, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, PPARA, SRC, TRPV1 |
8.57991 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, ADRB2, AKR1B1, AR, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, SRC, TRPV1 |
8.54342 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MCL1, MET, MMP9, SRC, XDH |
8.51402 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MCL1, MET, MMP9, SRC, XDH |
8.48983 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
8.37369 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESR1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MCL1, MET, MMP9, SRC, XDH |
7.65151 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, FABP3, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, TRPV1 |
7.59269 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, HSD17B3, HTR2B, HTR2C, PIM1, PPARA, XDH |
7.40401 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, F2, GPER1, HTR2A, HTR2B, HTR2C, KDR, SRC, TRPV1 |
7.31005 |
[BP] GO:0006811 |
None
|
ABCB1, ADRA1A, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, FABP3, HTR2A, HTR2B, HTR2C, KCNH2, PPARA, TRPV1 |
7.31005 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MCL1, MET, MMP9, MTNR1B, SRC, XDH |
7.19938 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MCL1, MET, MMP9, MTNR1B, SRC, XDH |
7.0647 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, ALOX5, AR, AXL, BCL2, CHRNA3, CHRNA7, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F2, FABP4, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1 |
6.97177 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, TRPV1 |
6.97177 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, MMP9, MTNR1A, SRC, XDH |
6.97177 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, MMP9, MTNR1A, SRC, XDH |
6.97177 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MCL1, MET, MMP9, SRC, XDH |
6.97177 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
6.97177 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA1A, ADRA1D, AKR1B1, AR, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESR1, ESRRA, F2, FABP3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
6.37968 |
[BP] GO:0007165 |
signal transduction
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AR, AXL, BCL2, CA1, CA2, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MCL1, MET, MMP2, MMP9, MTNR1A, MTNR1B, PIM1, PPARA, SRC, TRPV1 |
6.28754 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, TRPV1 |
6.18958 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESRRA, F2, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MCL1, MET, MMP2, MMP9, SRC, XDH |
6.16722 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, MMP9, SRC, XDH |
6.09568 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA1D, AKR1B1, AR, BCL2, CHRNA7, CSNK2A1, ESR1, F2, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1 |
5.96642 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, MTNR1A, PPARA, SRC, XDH |
5.93085 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, MTNR1A, PPARA, SRC, XDH |
5.87195 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F2, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MCL1, MET, MMP2, MMP9, PPARA, SRC, XDH |
5.87195 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.86852 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.86674 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.74778 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.72993 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
5.70748 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, SRC |
5.70267 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
5.70267 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.69532 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, SRC |
5.64595 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, ESRRB, F2, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
5.62447 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, MMP9, SRC, XDH |
5.62447 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, ADRA1B, ADRA1D, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.5904 |
[BP] GO:0007187 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CNR2, GPER1, HTR6, MTNR1A, MTNR1B |
5.57091 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, BCL2, CA2, CA9, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, SRC |
5.54148 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CHRNA3, CYP19A1, CYP1A1, CYP1B1, ESR1, GPER1, HSD17B1, HSD17B3, HTR2A, HTR2C, MTNR1B |
5.54148 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADRA1A, ADRA1B, ADRB2, AR, CHRNA7, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, SRC, XDH |
5.52707 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, BCL2, CA2, CHRNA7, CYP1B1, ESRRB, F2, GPER1, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SRC, TRPV1 |
5.51861 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.51861 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
5.51555 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.42499 |
[BP] GO:0007200 |
None
|
ADRA1A, ADRA1B, ADRA1D, ESR1, HTR2A, HTR2B, HTR2C |
5.39362 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, TRPV1 |
5.24013 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.23081 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADRA1A, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F2, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MCL1, MMP2, MMP9, PPARA, SRC, TRPV1 |
5.15791 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, HSD17B3, HTR2A, HTR2B, KDR, MCL1, MET, MMP2, MMP9, PIM1, PPARA, SRC |
5.1202 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, MCL1, TRPV1 |
5.12014 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, ADRA1B, ADRA1D, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
5.12014 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B3, KDR, PPARA, SRC |
5.08754 |
[BP] GO:0042310 |
None
|
ADRA1A, ADRA1B, ADRA1D, HTR2A, HTR2B |
5.05505 |
[BP] GO:0003018 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1, HTR2A, HTR2B, SRC |
5.0068 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, AURKB, BCL2, CHRNA3, CHRNA7, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PPARA, SRC, TRPV1, XDH |
5.0068 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, F2, GPER1, HTR2A, HTR2B, HTR2C, KDR, SRC, TRPV1 |
5.0068 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, BCL2, CYP19A1, ESR1 |
4.99507 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SRC, TRPV1, XDH |
4.94709 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADRA1A, ADRB2, CA2, CA7, CHRNA3, CHRNA7, CNR2, GPER1, HTR2A |
4.94709 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADRA1A, ADRB2, CA2, CA7, CHRNA3, CHRNA7, CNR2, GPER1, HTR2A |
4.94709 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
4.92976 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, F2, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, SRC, XDH |
4.89512 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B3 |
4.85248 |
[BP] GO:0042391 |
None
|
ADRA1A, ADRB2, BCL2, CHRNA3, CHRNA7, CNR2, GPER1, KCNH2, KDR, SRC, TRPV1 |
4.82341 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADRA1A, ADRA1B, ADRB2, AR, CHRNA7, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, SRC, XDH |
4.82341 |
[BP] GO:0006940 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRNA3, GPER1 |
4.82341 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
4.80679 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, GPER1, SRC, TRPV1 |
4.77309 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADRB2, AR, AXL, BCL2, CA2, CA7, CHRNA3, CSNK2A1, CYP19A1, CYP1B1, F2, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP9, MTNR1B, PPARA, SRC, TRPV1 |
4.74847 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, AURKB, BCL2, CHRNA3, CHRNA7, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PPARA, SRC, TRPV1, XDH |
4.71053 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, BCL2, CA2, CHRNA3, CHRNA7, CYP1B1, ESR1, ESRRA, ESRRB, F2, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, KDR, MET, MMP9, PIM1, SRC, TRPV1, XDH |
4.65273 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA1A, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MCL1, MET, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
4.64533 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, AURKB, BCL2, CHRNA3, CHRNA7, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PPARA, SRC, TRPV1, XDH |
4.60459 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
4.58897 |
[BP] GO:0001994 |
None
|
ADRA1A, ADRA1B, ADRA1D |
4.58897 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.58897 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B3 |
4.50983 |
[BP] GO:0097746 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1, HTR2A, HTR2B |
4.50847 |
[BP] GO:0035296 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1, HTR2A, HTR2B |
4.50847 |
[BP] GO:0097756 |
None
|
ADRA1A, ADRA1B, ADRA1D, HTR2A, HTR2B |
4.4973 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, ADRA1B, ADRA1D, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, SRC |
4.48565 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRB2, AKR1B1, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KCNH2, KDR, MMP2, MMP9, SRC, TRPV1 |
4.47903 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.47903 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, HTR2B, IGF1R, KDR, MCL1, MMP9, PIM1, SRC, TRPV1, XDH |
4.39467 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B3, MET, PPARA, TRPV1 |
4.35535 |
[BP] GO:0050880 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1, HTR2A, HTR2B |
4.35185 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, MMP9, SRC, XDH |
4.35185 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, CHRNA7, GPER1, HTR2A, HTR2B, HTR2C, KDR, SRC |
4.34224 |
[BP] GO:0035150 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1, HTR2A, HTR2B |
4.33792 |
[BP] GO:0006810 |
None
|
ABCB1, ACHE, ADRA1A, ADRB2, ALOX5, AR, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, F2, FABP3, HTR2A, HTR2B, HTR2C, KCNH2, MCL1, MMP9, PPARA, SRC, TRPV1, XDH |
4.32673 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, F2, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, PPARA, SRC |
4.3175 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC |
4.30592 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.26375 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SRC |
4.23601 |
[BP] GO:0003013 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1, HTR2A, HTR2B, SRC |
4.23601 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2 |
4.10661 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ADRA1A, ADRB2, ALOX5, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, ESR1, F2, FABP3, HTR2A, HTR2B, HTR2C, KCNH2, MCL1, MMP9, PPARA, SRC, TRPV1, XDH |
4.10536 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRA1A, ADRA1B, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESR1, ESR2, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MCL1, MET, MMP9, SRC, XDH |
4.08444 |
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ADRA1A, ADRB2, ALOX5, AR, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, F2, FABP3, HTR2A, HTR2B, HTR2C, KCNH2, MCL1, MMP9, PPARA, SRC, TRPV1, XDH |
3.98027 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1 |
3.98027 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, CSNK2A1, ESR1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, MMP9, SRC, XDH |
3.97369 |
[BP] GO:0007154 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, BCL2, CHRNA3, ESR2, HTR2A, HTR2C, HTR6, MTNR1B, TRPV1 |
3.96402 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SRC |
3.96402 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, BCL2, CA3, CHRNA7, CNR2, CYP1A1, CYP1B1, KDR, SRC |
3.96402 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB2, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MTNR1A, PPARA, SRC, TRPV1 |
3.91227 |
[BP] GO:0007210 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.82169 |
[BP] GO:0098664 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.82169 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2 |
3.82169 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.78869 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA1A, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MCL1, MET, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
3.78309 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADRA1A, ADRA1B, ADRA1D, AKR1B1, AR, AXL, BCL2, CA2, CHRNA3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, FLT3, HSD17B3, KDR, MCL1, MMP9, PIM1, PPARA, SRC |
3.77538 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADRB2, AXL, BCL2, CA2, CA7, CHRNA3, CYP19A1, F2, GPER1, HTR2A, HTR2B, HTR2C, KCNH2, MMP9, MTNR1B, PPARA, SRC, TRPV1 |
3.75963 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, ESR1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KDR, MMP9, SRC, XDH |
3.69935 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1, HSD17B3 |
3.69935 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRB2, AKR1B1, AR, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, SRC, TRPV1 |
3.68968 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA1A, ADRA1B, ADRB2, AR, AURKB, BCL2, CHRNA3, CHRNA7, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PPARA, SRC, XDH |
3.64634 |
[BP] GO:0051282 |
None
|
F2, GPER1, HTR2A, HTR2B, HTR2C, TRPV1 |
3.60021 |
[BP] GO:1901652 |
response to peptide
|
ADRB2, AKR1B1, CHRNA7, FABP3, GPER1, IGF1R, PPARA, SRC, TRPV1 |
3.57513 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADRA1A, ADRB2, AR, AURKB, BCL2, CHRNA3, CHRNA7, ESR1, ESR2, F2, FLT3, GPER1, HTR2A, HTR2B, MET, MMP9, SRC, XDH |
3.56104 |
[BP] GO:0060402 |
None
|
ADRA1A, HTR2A, HTR2B, HTR2C, TRPV1 |
3.56104 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADRB2, AKR1B1, CHRNA3, CHRNA7, CNR2, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, SRC, TRPV1 |
3.52662 |
[BP] GO:0023052 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, CHRNA3, ESR2, HTR2A, HTR2C, HTR6, KCNH2, MTNR1B |
3.48651 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADRA1A, ADRA1B, ADRB2, AR, BCL2, CHRNA3, CHRNA7, F2, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, SRC, XDH |
3.47429 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADRA1A, ADRB2, AR, AURKB, BCL2, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, F2, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
3.449 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADRA1A, ADRB2, CA2, CA7, CHRNA7, GPER1 |
3.449 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, HTR2A, PPARA, SRC |
3.44411 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA1A, ADRB2, AR, BCL2, CNR2, ESR1, ESR2, GPER1, HTR2A, IGF1R, MCL1, MET, MMP9, SRC, XDH |
3.42685 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, CHRNA7, GPER1, HTR2A, HTR2B, HTR2C, KDR, SRC |
3.41411 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA1A, ADRB2, AR, BCL2, CNR2, ESR1, ESR2, GPER1, HTR2A, IGF1R, MCL1, MET, MMP9, SRC, XDH |
3.41411 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CA2, CNR2, ESR1, F2, GPER1, HTR2A, HTR2B, HTR2C, HTR6, MTNR1A, MTNR1B, SRC |
3.41208 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADRA1D, ADRB2, AKR1B1, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B3, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, PIM1, PPARA, SRC, XDH |
3.39155 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7, CNR2 |
3.3755 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.36661 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MMP9, PIM1, SRC |
3.36661 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1 |
3.34381 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.33987 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.33987 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.33618 |
[BP] GO:0045907 |
None
|
ADRA1A, ADRA1B, ADRA1D, HTR2A |
3.33618 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, MTNR1A, MTNR1B, PPARA, SRC |
3.326 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADRB2, BCL2, CA2, CA7, CHRNA3, F2, GPER1, HTR2A, KCNH2, MMP9 |
3.30211 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA1A, ADRB2, AR, BCL2, CNR2, CYP19A1, ESR1, ESR2, F2, GPER1, IGF1R, MCL1, MET, MMP9, PPARA, SRC, XDH |
3.29556 |
[BP] GO:0045987 |
None
|
ADRA1A, ADRA1B, ADRA1D, GPER1 |
3.29163 |
[BP] GO:0043393 |
regulation of protein binding
|
ADRB2, AURKB, BCL2, MET, MMP9, PPARA, SRC |
3.2624 |
[BP] GO:0060401 |
None
|
ADRA1A, HTR2A, HTR2B, HTR2C, TRPV1 |
3.25158 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.22854 |
[BP] GO:0034764 |
None
|
ABCB1, ADRB2, CA2, F2, GPER1, KCNH2 |
3.21313 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
ADRB2, AKR1B1, AR, AXL, CYP1B1, ESR1, GPER1, IGF1R, MMP2, MMP9, SRC, TRPV1 |
3.21257 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KCNH2, KDR, MCL1, MMP2, MMP9, SRC, TRPV1 |
3.21257 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.21257 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.21257 |
[BP] GO:0007267 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, CHRNA3, ESR2, HTR2A, HTR2C, HTR6, MTNR1B |
3.21138 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADRB2, AKR1B1, CHRNA7, CNR2, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, SRC, TRPV1 |
3.18259 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AXL, BCL2, CYP1B1, GPER1, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MCL1, MET, SRC |
3.1711 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, ESR1, GPER1, IGF1R, MCL1, MET, MMP9, SRC, XDH |
3.14355 |
[BP] GO:0044057 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRNA3, GPER1, HTR2A, HTR2C, KCNH2, TRPV1 |
3.13332 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
3.13332 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADRA1D, ADRB2, AKR1B1, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B3, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
3.12696 |
[BP] GO:0032845 |
None
|
BCL2, HTR2A, HTR2B, HTR2C, SRC, TRPV1 |
3.09869 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.02405 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.98436 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.98436 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.92997 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1, HTR2B, KDR |
2.92746 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB2, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, MET, MTNR1A, PPARA, SRC, TRPV1 |
2.92682 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1 |
2.92122 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADRB2, AXL, BCL2, CA2, CYP19A1, F2, GPER1, HTR2B, KCNH2, SRC, TRPV1 |
2.88819 |
[BP] GO:0051209 |
None
|
HTR2A, HTR2B, HTR2C, TRPV1 |
2.86449 |
[BP] GO:0051283 |
None
|
HTR2A, HTR2B, HTR2C, TRPV1 |
2.86449 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.86395 |
[BP] GO:0006937 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRNA3, GPER1 |
2.85224 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, ALOX5, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, GPER1, HSD17B1, HSD17B3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MCL1, MET, MMP1, MMP2, MMP9, MTNR1A, MTNR1B, PIM1, PPARA, SRC, TRPV1, XDH |
2.77468 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, MCL1, SRC |
2.77082 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.77082 |
[BP] GO:0006939 |
None
|
ADRA1A, HTR2A, HTR2B, TRPV1 |
2.76633 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AR, CYP1A1, CYP1B1, ESR1, FLT3, GPER1, SRC, TRPV1 |
2.74789 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, GPER1 |
2.74748 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.73576 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADRB2, AKR1B1, AURKB, BCL2, CA2, CHRNA7, CYP1A1, HTR2A, HTR2B, MMP2, PPARA, SRC, TRPV1 |
2.729 |
[BP] GO:0045933 |
None
|
ADRA1A, ADRA1B, ADRA1D, GPER1 |
2.70414 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB2, AR, AXL, BCL2, CA2, CHRNA3, CHRNA7, CYP1B1, ESR1, ESRRA, ESRRB, F2, GPER1, HTR2A, HTR2C, KDR, PIM1, PPARA, SRC, TRPV1, XDH |
2.69143 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.68443 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.64473 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB2, MMP1, MMP2, MMP9, TRPV1 |
2.64071 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.60665 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.60665 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B3, SRC |
2.59307 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.57356 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57356 |
[BP] GO:1905144 |
None
|
CHRNA3, CHRNA7 |
2.57356 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.57356 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADRA1A, ADRB2, AR, AURKB, BCL2, CHRNA3, CHRNA7, CNR2, CSNK2A1, ESR1, F2, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, MMP9, SRC, XDH |
2.56882 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.5468 |
[BP] GO:0003008 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, BCL2, CHRNA7, CNR2, CYP1B1, GPER1, HTR2A, HTR2B, KCNH2, SRC, TRPV1 |
2.52092 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.51267 |
[BP] GO:0097553 |
None
|
HTR2A, HTR2B, HTR2C, TRPV1 |
2.51267 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
CNR2, CYP19A1, F2, GPER1, PPARA |
2.49692 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.49416 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KCNH2, KDR, SRC, TRPV1 |
2.49416 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.45971 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.45423 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADRB2, AKR1B1, HTR2A, MET, TRPV1 |
2.45129 |
[BP] GO:0019229 |
None
|
ADRA1A, ADRA1B, ADRA1D, HTR2A |
2.43557 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B3 |
2.40876 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.39945 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.39799 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.3871 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRB2, AR, AXL, BCL2, CA2, CHRNA7, CYP1B1, ESRRB, GPER1, HTR2A, HTR2C, KDR, PIM1, SRC |
2.38007 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, MCL1, SRC |
2.35054 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35054 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.34427 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
2.34342 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.31743 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.31743 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.3085 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.3085 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.3085 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
F2, FLT3, GPER1, KDR |
2.3042 |
[BP] GO:0007610 |
None
|
BCL2, CHRNA3, CHRNA7, HTR2A, HTR2B, HTR2C, MTNR1A, PPARA, TRPV1 |
2.30124 |
[BP] GO:0034767 |
None
|
ABCB1, ADRB2, F2, GPER1, KCNH2 |
2.27128 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRB2, AKR1B1, AR, ESR1, FLT3, GPER1, IGF1R, MMP2, SRC, TRPV1 |
2.24641 |
[BP] GO:1903524 |
None
|
ADRA1A, ADRA1B, ADRA1D, HTR2A |
2.21055 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, BCL2, CA2, FLT3, GPER1, SRC |
2.21055 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, F2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC |
2.21055 |
[BP] GO:0010507 |
negative regulation of autophagy
|
BCL2, HTR2B, MCL1, MET |
2.19423 |
[BP] GO:0034762 |
None
|
ABCB1, ADRB2, BCL2, CA2, F2, GPER1, KCNH2, MMP9 |
2.16522 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRB2, AURKB, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
2.15156 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADRA1A, ADRA1B, ADRB2, AR, AURKB, BCL2, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MCL1, MET, MMP9, MTNR1A, PIM1, PPARA, SRC, TRPV1, XDH |
2.15105 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ADRB2, AR, AURKB, AXL, BCL2, ESR1, GPER1, IGF1R, KDR, MET, MMP1, MMP9, SRC |
2.1357 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.13355 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.13355 |
[BP] GO:0090257 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRNA3, GPER1 |
2.13355 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.13355 |
[BP] GO:0071502 |
None
|
HTR2B, TRPV1 |
2.13355 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, ADRB2, AR, BCL2, ESR1, ESR2, GPER1, IGF1R, MCL1, MET, MMP9, SRC, XDH |
2.0973 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, F2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, SRC |
2.08446 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.07617 |
[BP] GO:1904645 |
response to amyloid-beta
|
ADRB2, CHRNA7, IGF1R |
2.04891 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
AR, AURKB, BCL2, CHRNA7, CNR2, CSNK2A1, ESR1, ESR2, ESRRA, F2, FABP4, GPER1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PPARA, SRC, TRPV1, XDH |
2.04094 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CA3, CYP1B1, MMP9, SRC |
2.04094 |
[BP] GO:0051098 |
regulation of binding
|
ADRB2, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.04094 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.04094 |
[BP] GO:0051046 |
None
|
ACHE, CHRNA3, CYP19A1, GPER1, HTR2A, HTR2B, HTR2C, MTNR1B, SRC, TRPV1 |
2.02813 |
[BP] GO:0006816 |
None
|
ADRA1A, CHRNA7, HTR2A, HTR2B, HTR2C, TRPV1 |
2.01771 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R |
2.01771 |
[BP] GO:0001659 |
None
|
ADRB2, HTR2A, TRPV1 |
2.01771 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, GPER1, HSD17B1, HSD17B3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MCL1, MET, MMP1, MMP2, MMP9, MTNR1A, MTNR1B, PIM1, PPARA, SRC, TRPV1, XDH |
2.00951 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADRB2, AKR1B1, AXL, BCL2, CA2, CA3, CA9, CHRNA7, CNR2, CYP1A1, CYP1A2, CYP1B1, F2, GPER1, HTR2C, MCL1, MMP2, MMP9, PPARA, SRC, TRPV1 |
2.0033 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CA2, CA4, CA9, CHRNA3, CHRNA7, CNR2, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MTNR1A, MTNR1B, SRC, TRPV1 |
5.17278 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, CA12, CA14, CA2, CA4, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, ESR1, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MMP2, MTNR1A, MTNR1B, PIM1, SRC, TRPV1 |
5.12014 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CA4, CNR2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, TRPV1 |
4.53571 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CNR2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, TRPV1 |
4.17195 |
[CC] GO:0044853 |
plasma membrane raft
|
ADRA1A, ADRA1B, CHRNA3, CHRNA7, HTR2A, SRC |
4.07761 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADRA1A, ADRA1B, ADRB2, CA2, CA4, CA9, CHRNA3, CHRNA7, GPER1, HTR2A, MET, SRC, TRPV1 |
3.43967 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, ALOX5, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F2, FLT3, FUT7, GPER1, HSD17B3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MCL1, MET, MMP2, MTNR1A, MTNR1B, PIM1, SRC, TRPV1 |
3.28862 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRNA3, CHRNA7, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F2, FLT3, FUT7, GPER1, HSD17B3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MCL1, MET, MTNR1A, MTNR1B, SRC, TRPV1 |
2.80361 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, ADRA1B, CHRNA3, CHRNA7, HTR2A, KDR, SRC |
2.39945 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, ADRA1B, CHRNA3, CHRNA7, HTR2A, KDR, SRC |
2.38599 |
[CC] GO:0005901 |
caveola
|
ADRA1A, ADRA1B, HTR2A, SRC |
2.19423 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.2026 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, XDH |
13.1235 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.0026 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
11.7108 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.585 |
[MF] GO:0004872 |
receptor activity
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
10.5902 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
10.2857 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AR, AXL, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
9.67114 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, AOX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, HSD17B1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1, XDH |
8.77047 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA |
8.16004 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, CHRNA3, CHRNA7, GPER1, HSD17B1, IGF1R, MTNR1A, SHBG |
8.15209 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, HTR2A, HTR2B, HTR2C, HTR6 |
7.99643 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
7.82085 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.93371 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.93371 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, SHBG |
6.72268 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, HTR2A, HTR2B, HTR2C, MMP1, MMP2, MMP9, PIM1, PPARA, TRPV1, XDH |
6.69741 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.37968 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CHRNA3, CHRNA7, CNR2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, TRPV1 |
6.10788 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CHRNA3, CHRNA7, CNR2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, TRPV1 |
6.10788 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, PIM1, PPARA, SRC, TRPV1 |
5.38519 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, CHRNA3, CHRNA7, HTR2A, HTR2B, HTR2C |
5.30152 |
[MF] GO:0004937 |
None
|
ADRA1A, ADRA1B, ADRA1D |
5.08754 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPER1, HSD17B1, PPARA, SHBG, TRPV1 |
5.08754 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRNA3, CHRNA7, HTR2A, HTR2B, HTR2C |
4.56079 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2 |
4.47903 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.26375 |
[MF] GO:0004936 |
None
|
ADRA1A, ADRA1B, ADRA1D |
3.98823 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.88319 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.86093 |
[MF] GO:0004993 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.82169 |
[MF] GO:0099589 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.82169 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.69417 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP2, MMP9, PIM1, PPARA, TRPV1, XDH |
3.69393 |
[MF] GO:0030594 |
None
|
CHRNA3, CHRNA7, HTR2A, HTR2B, HTR2C, HTR6 |
3.68424 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.61762 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F2, FLT3, FUT7, HSD17B1, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, MMP9, PIM1, SRC, XDH |
3.57319 |
[MF] GO:0043176 |
None
|
HTR2A, HTR2B, HTR2C |
3.22854 |
[MF] GO:0051378 |
None
|
HTR2A, HTR2B, HTR2C |
3.22854 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.18936 |
[MF] GO:0099528 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.13332 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.98436 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.98436 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.86449 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRB2, AOX1, BCL2, CHRNA7, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MCL1, MET, MMP9, TRPV1, XDH |
2.85224 |
[MF] GO:0042166 |
None
|
ACHE, CHRNA3, CHRNA7 |
2.69991 |
[MF] GO:0004930 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CNR2, GPER1, HTR2A, HTR2B, HTR2C, HTR6, MTNR1A, MTNR1B |
2.66104 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.60665 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.59995 |
[MF] GO:0008502 |
None
|
MTNR1A, MTNR1B |
2.57356 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.38351 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.31743 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.31743 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.31027 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRB2, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PIM1, PPARA, SRC |
2.21055 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, HSD17B1, HSD17B3, XDH |
2.20283 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.17711 |
[MF] GO:0051434 |
BH3 domain binding
|
BCL2, MCL1 |
2.13355 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B3, XDH |
2.04567 |